elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38979882-AD4F3BDC-5D2C-4CA4-8C81-70ACCA6A3E58
Q38979882-AD4F3BDC-5D2C-4CA4-8C81-70ACCA6A3E58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-AD4F3BDC-5D2C-4CA4-8C81-70ACCA6A3E58
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
P2860
Q38979882-AD4F3BDC-5D2C-4CA4-8C81-70ACCA6A3E58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-AD4F3BDC-5D2C-4CA4-8C81-70ACCA6A3E58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2763e4c0e26e27b3af790892a90a869f6ed45005
P2860
Anti-VEGF/VEGFR therapy for cancer: reassessing the target.